132 related articles for article (PubMed ID: 436757)
1. Mechanism of action of a new antialdosterone compound, prorenone.
Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
[TBL] [Abstract][Full Text] [Related]
2. Binding and antimineralocorticoid activities of spirolactones in toad bladder.
Rossier BC; Claire M; Rafestin-Oblin ME; Geering K; Gäggeler HP; Corvol P
Am J Physiol; 1983 Jan; 244(1):C24-31. PubMed ID: 6217754
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
Wambach G; Casals-Stenzel J
Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
[TBL] [Abstract][Full Text] [Related]
4. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
[TBL] [Abstract][Full Text] [Related]
5. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.
Luzzani F; Glässer A
Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813
[TBL] [Abstract][Full Text] [Related]
6. RU-26988--a new tool for the study of the mineralocorticoid receptor.
Gomez-Sanchez CE; Gomez-Sanchez EP
Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
[TBL] [Abstract][Full Text] [Related]
7. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
[TBL] [Abstract][Full Text] [Related]
8. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors.
Ulmann A; Menard J; Corvol P
Endocrinology; 1975 Jul; 97(1):46-51. PubMed ID: 166832
[TBL] [Abstract][Full Text] [Related]
9. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Casals-Stenzel J; Buse M; Wambach G; Losert W
Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogenic effect of spirolactones: mechanism of action.
Corvol P; Michaud A; Menard J; Freifeld M; Mahoudeau J
Endocrinology; 1975 Jul; 97(1):52-8. PubMed ID: 166833
[TBL] [Abstract][Full Text] [Related]
11. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors.
Claire M; Faraj H; Grassy G; Aumelas A; Rondot A; Auzou G
J Med Chem; 1993 Aug; 36(16):2404-7. PubMed ID: 8360885
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid (type I) receptors in the olfactory mucosa of the mammal: studies with [3H]aldosterone and the anti-mineralocorticoid spironolactone.
Kern RC; Foster JD; Pitovski DZ
Chem Senses; 1997 Apr; 22(2):141-8. PubMed ID: 9146904
[TBL] [Abstract][Full Text] [Related]
14. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptors in the epithelial cells of human colon and ileum.
Rafestin-Oblin ME; Lombes M; Michiel JB; Michaud A; Claire M
J Steroid Biochem; 1984 Jan; 20(1):311-5. PubMed ID: 6323865
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors in human kidney.
Matulich DT; Spindler BJ; Schambelan M; Baxter JD
J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic evidence of nuclear binding of spironolactone in rabbit cortical collecting tubule.
Bonvalet JP; Blot-Chabaud M; Farman N
Endocrinology; 1991 Jan; 128(1):280-4. PubMed ID: 1986923
[TBL] [Abstract][Full Text] [Related]
18. Receptor binding and biological activity of 18-oxocortisol.
Gomez-Sanchez CE; Gomez-Sanchez EP; Smith JS; Ferris MW; Foecking MF
Endocrinology; 1985 Jan; 116(1):6-10. PubMed ID: 2856875
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid-binding studies in cytosol of colonic mucosa of the rat.
Marusic ET; Hayslett JP; Binder HJ
Am J Physiol; 1981 Jun; 240(6):G417-23. PubMed ID: 7246742
[TBL] [Abstract][Full Text] [Related]
20. Binding of natural spirolactone derivatives to mineralo- and glucocorticoid receptors of the rat kidney.
Palem-Vliers M; Genard P; Hacha R; Christiaens L; Lomba-Pignon MR
Arch Int Physiol Biochim; 1987 Nov; 95(4):373-4. PubMed ID: 2453182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
